Company: ARTL
Filing Date: 2025-07-11
Form Type: S-1
Source: 0001640334-25-001190
Chunk: 15

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-07-11
Form: S-1
Chunk 15
---
| 6 |

| The Offering                                                  |     |                                                                                                                                                                                                                                                                                                                                                                |
| Shares of Common Stock Offered by the Selling Securityholders |     | 920,092 shares of Common Stock, consisting of: (i) 136,843 shares of Common Stock, (ii) 93,180 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants, (iii) 460,046 shares of Common Stock issuable upon the exercise of the $5.82 Warrants, and (iv) 230,023 shares of Common Stock issuable upon the exercise of the $10.00 Warrants. |
| Use of proceeds                                               |     | We will not receive any proceeds from any sale of the shares being offered for sale by the Selling Securityholders. We will, however, receive the net proceeds of any Warrants exercised for cash.                                                                                                                                                             |
| Dividend policy                                               |     | We have never declared or paid any cash dividends on our shares of Common Stock. We do not anticipate paying any cash dividends in the foreseeable future.                                                                                                                                                                                                     |
| Risk factors                                                  |     | You should carefully consider the risk factors described in the section of this prospectus entitled “Risk Factors,” together with all of the other information included in this prospectus, before deciding to purchase our shares of Common Stock.                                                                                                            |
| Market and trading symbol                                     |     | Our shares of Common Stock are traded on the Nasdaq Capital Market under the symbol “ARTL.”                                                                                                                                                                                                                                                                    |

| 7 |

<div align='center'>RISK FACTORS</div>

An investment in our securities involves a high degree of risk. Our business, financial condition or results of operations could be materially and adversely affected by any of these risks. If any of these risks occur, the value of our shares of Common Stock and our other securities may decline. Before making your investment decision, you should carefully consider the risks together with all of the other information contained or incorporated by reference in this prospectus, including any risks in the section entitled “Risk Factors” contained in any supplements to this prospectus, in our Quarterly Report on Form 10-Q filed with the SEC on May 13, 2025, and in our subsequent filings with the SEC. Each of the referenced risks and uncertainties could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment in our securities. Additional risks not known to us or that we believe are immaterial may also adversely affect our business, operating results